Prediction of engraftment after autologous peripheral blood progenitor cell transplantation: CD34, colony-forming unit-granulocyte-macrophage, or both?

Transfusion

Volumn 47, Issue 5, 2007, Pages 817-823

  Jansen, Eva M ^a   Hanks, Susan G ^a   Terry, Colin ^a   Akard, Luke P ^a   Thompson, James M ^a   Dugan, Michael J ^a   Jansen, Jan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA;

ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BREAST CANCER; CD34 SELECTION; COLONY FORMING UNIT GM; CONTROLLED STUDY; CORRELATION ANALYSIS; ENGRAFTMENT; ERYTHROCYTE; HUMAN; HUMAN CELL; LYMPHOMA; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; PREDICTION; THROMBOCYTE COUNT;

ANTIGENS, CD34; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; GRANULOCYTES; HUMANS; KAPLAN-MEIERS ESTIMATE; LINEAR MODELS; LYMPHOMA; MACROPHAGES; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; MYELOID PROGENITOR CELLS; NEOPLASMS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STEM CELLS; TRANSPLANTATION, AUTOLOGOUS;

EID: 34247567527     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01195.x     Document Type: Article

References (18)

1. Haas R, Moble R, Frühauf S, et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994 83 : 3787 94.
2. Haynes A, Hunter A, McQuaker G, et al. Engraftment characteristics of peripheral blood stem cell mobilized with cyclophosphamide and the delayed addition of G-CSF. Bone Marrow Transplant 1995 16 : 359 63.
3. Tricot G, Jagannath S, Vesole D, et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 1995 85 : 588 96.
4. Weaver CH, Hazelton B, Birch B, et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995 86 : 3961 9.
5. Ketterer N, Salles G, Raba M, et al. High CD34+ cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation. Blood 1998 91 : 3148 55.
6. Shpall EJ, Champlin R, Glaspy JA. Effect of CD34+ peripheral blood progenitor cell dose on hematopoietic recovery. Biol Blood Marrow Transplant 1998 4 : 84 92.
7. Siena S, Schiava R, Pedrazzoli P, et al. Therapeutic relevance of CD34+ cell dose in blood cell transplantation for cancer therapy. J Clin Oncol 2000 18 : 1360 77.
8. Jonkhoff AR, De Kreuk AM, Franschman G, et al. Granulocyte colony-stimulating factor mobilized whole blood containing over 0.3 x 106/kg CD34+ cells is a sufficient graft in autologous transplantation for relapsed non-Hodgkin's lymphoma. Br J Haematol 2002 118 : 90 100.
9. Kessinger A, Armitage JD, Smith DM, et al. High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood 1989 74 : 1260 5.
10. To LB, Dyson PG, Juttner CA. Cell-dose effect in circulating stem-cell autografting. Lancet 1986 2 : 404 5.
11. Gianni AM, Bregni M, Siena S, et al. Rapid and complex hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells: a changing role for high-dose chemo-radiotherapy. Hematol Oncol 1989 7 : 139 48.
12. Siena S, Bregni M, Brando B, et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991 77 : 400 9.
13. Sutherland DR, Anderson L, Keeney M, et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J Hematother 1996 5 : 213 26.
14. Serke S, Watts M, Knudsen LM, et al. In-vitro clonogenicity of mobilized peripheral-blood CD34-expressing cells: inverse correlation to both relative and absolute numbers of CD34-expressing cells. Br J Haematol 1996 95 : 234 40.
15. Brandt SJ, Peters WP, Atwater SK, et al. Effect of recombinant granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med 1988 318 : 869 76.
16. Schulman KA, Birch R, Zhen B, Pania N, Weaver CH. Effect of CD34+ cell dose on resource utilization in patients after high-dose chemotherapy with peripheral-blood stem-cell support. J Clin Oncol 1999 17 : 1227 33.
17. Limat S, Woronoff-Lemsi MC, Deconinck E, et al. Cost-effectiveness of CD34+ dose in peripheral blood progenitor cell transplantation for non-Hodgkin's lymphoma patients: a single centre study. Bone Marrow Transplant 2000 25 : 997 1002.
18. Sawada K. Growth characteristics of myelodysplasia. Leuk Lymphoma 1998 29 : 49 60.